Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis.

Allen DW, Ma B, Leung KC, Graham MM, Pannu N, Traboulsi M, Goodhart D, Knudtson ML, James MT.

Can J Cardiol. 2017 Jun;33(6):724-736. doi: 10.1016/j.cjca.2017.01.018. Epub 2017 Feb 1. Review.

PMID:
28545621
2.

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.

Newby LK, Marber MS, Melloni C, Sarov-Blat L, Aberle LH, Aylward PE, Cai G, de Winter RJ, Hamm CW, Heitner JF, Kim R, Lerman A, Patel MR, Tanguay JF, Lepore JJ, Al-Khalidi HR, Sprecher DL, Granger CB; SOLSTICE Investigators.

Lancet. 2014 Sep 27;384(9949):1187-95. doi: 10.1016/S0140-6736(14)60417-7. Epub 2014 Jun 12. Erratum in: Lancet. 2014 Sep 27;384(9949):1186.

PMID:
24930728
3.

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study.

Natarajan MK, Strauss BH, Rokoss M, Buller CE, Mancini GB, Xie C, Sheth TN, Goodhart D, Cohen EA, Seidelin P, Harper W, Gerstein HC.

Cardiovasc Revasc Med. 2012 Mar-Apr;13(2):95-100. doi: 10.1016/j.carrev.2011.12.001. Epub 2012 Jan 30.

PMID:
22296781
4.

An early cardiac access clinic significantly improves cardiac rehabilitation participation and completion rates in low-risk ST-elevation myocardial infarction patients.

Parker K, Stone JA, Arena R, Lundberg D, Aggarwal S, Goodhart D, Traboulsi M.

Can J Cardiol. 2011 Sep-Oct;27(5):619-27. doi: 10.1016/j.cjca.2010.12.076. Epub 2011 Apr 7.

PMID:
21477969
5.

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.

FUTURA/OASIS-8 Trial Group, Steg PG, Jolly SS, Mehta SR, Afzal R, Xavier D, Rupprecht HJ, López-Sendón JL, Budaj A, Diaz R, Avezum A, Widimsky P, Rao SV, Chrolavicius S, Meeks B, Joyner C, Pogue J, Yusuf S.

JAMA. 2010 Sep 22;304(12):1339-49. doi: 10.1001/jama.2010.1320. Epub 2010 Aug 31.

PMID:
20805623
6.

Obesity is associated with impaired human coronary endothelial function.

Worthley MI, Curtis MJ, Goodhart DM, Anderson TJ.

Obes Res Clin Pract. 2009 Mar;3(1):1-52. doi: 10.1016/j.orcp.2008.09.003.

PMID:
24345536
7.

Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

Hubacek J, Basran RS, Shrive FM, Shewchuk L, Goodhart DM, Anderson TJ; Foothills Interventional Cardiology Service Research Group.

Can J Cardiol. 2009 Feb;25(2):e42-7.

8.

Effect of PCI on quality of life in patients with stable coronary disease.

Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group, Mancini GB.

N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.

9.

Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries.

Worthley MI, Kanani RS, Sun YH, Sun Y, Goodhart DM, Curtis MJ, Anderson TJ.

Cardiovasc Res. 2007 Dec 1;76(3):539-46. Epub 2007 Jul 21.

PMID:
17689509
10.

Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.

Worthley MI, Anderson TJ, Traboulsi M, Charbonneau F, Curtis MJ, Hansen JL, Knudtson ML, Spence FP, Goodhart DM.

Heart Lung Circ. 2006 Oct;15(5):300-5. Epub 2006 Jul 28.

PMID:
16877042
11.

Effect of percutaneous coronary intervention of nonacute total coronary artery occlusions on QT dispersion.

Goodhart DM, Hubacek J, Anderson TJ, Duff H, Barbeau G, Ducas J, Carere RG, Lazzam C, Dzavik V, Buller CE, Traboulsi M; TOSCA investigators.

Am Heart J. 2006 Feb;151(2):529.e1-529.e6.

PMID:
16442926
12.

A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.

Natarajan MK, Velianou JL, Turpie AG, Mehta SR, Raco D, Goodhart DM, Afzal R, Ginsberg JS.

Am Heart J. 2006 Jan;151(1):175.

PMID:
16368313
13.

Large and small vessel vasoconstriction following coronary artery stenting. Effect of intra coronary nitroglycerine and relation to LDL cholesterol.

Larsen AI, Basran R, Anderson T, Goodhart D; FICS study group.

Int J Cardiol. 2006 Oct 26;113(1):61-5. Epub 2005 Dec 7.

PMID:
16337702
14.

Relation of Basal coronary nitric oxide activity to the burden of atherosclerosis.

Anderson TJ, Worthley MI, Goodhart DM, Curtis MJ.

Am J Cardiol. 2005 May 15;95(10):1170-4.

PMID:
15877988
15.

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.

Mehta SR, Steg PG, Granger CB, Bassand JP, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJ, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay JF, Fox KA, Yusuf S; ASPIRE Investigators.

Circulation. 2005 Mar 22;111(11):1390-7.

16.

Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention.

Chugh SK, Koppel J, Scott M, Shewchuk L, Goodhart D, Bonan R, Tardif JC, Worthley SG, DiMario C, Curtis MJ, Meredith IT, Anderson TJ.

J Am Coll Cardiol. 2004 Aug 18;44(4):778-82.

17.

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.

Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM.

Am J Cardiol. 2004 Mar 15;93(6):750-3.

PMID:
15019884
18.

The risks of waiting for cardiac catheterization: a prospective study.

Natarajan MK, Mehta SR, Holder DH, Goodhart DR, Gafni A, Shilton D, Afzal R, Teo K, Yusuf S.

CMAJ. 2002 Nov 26;167(11):1233-40. Erratum in: CMAJ. 2003 Jun 10;168(12):1529. CMAJ. 2003 Jan 21;168(2):152..

19.

'Primary intention' intracoronary stenting guided by angiography alone: a safe approach.

Goodhart DM, Galbraith D, Anderson TJ, Traboulsi M, Knudtson ML.

Can J Cardiol. 1999 Aug;15(8):873-8. English, French.

PMID:
10446434
20.

Prolonged sinus node recovery time in humans after the intracoronary administration of a nitric oxide synthase inhibitor.

Exner DV, Goodhart DM, Anderson TJ, Duff HJ.

J Cardiovasc Pharmacol. 1999 Jul;34(1):1-6.

PMID:
10413059

Supplemental Content

Loading ...
Support Center